Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805449 · ClinicalTrials.gov registry record · NA
BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma
A NA study of Anal Fistula, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05805449: Recruiting NA study of Anal Fistula, sponsored by The University of Texas Health Science Center, Houston.
NCT05805449 is a NA study of Anal Fistula that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 250 participants, roughly in line with the 252-participant average among 5 other Anal Fistula trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805449, a NA study of Anal Fistula, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the clinical effectiveness of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix (UBM) to usual surgical care alone to prevent fistula recurrence or improve HRQoL, to compare the effects of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix on early postoperative pain and fecal continence and to assess the cost utility of augmented complex fistula repair relative to usual surgical care
Conditions Studied
Interventions
- PROCEDURE Surgery
- OTHER Platelet-rich plasma (PRP)
- DEVICE Matrix
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT05805449 shows while recruiting
NCT05805449 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 252-participant average among 5 other Anal Fistula trials with a reported enrollment target.
The record links to 1 condition, with Anal Fistula appearing as the primary indexed condition, and to 3 interventions - of which Surgery is the first listed.
NCT05805449 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05805449 about?
NCT05805449 is a clinical study titled "BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma". The purpose of this study is to compare the clinical effectiveness of augmenting surgical repair of complex anal fistula using autologous PRP and/or micronized acellular porcine urinary bladder matrix (UBM) to usual surgical care alone to prevent fistula recurrence or improve HRQoL, to compare the e...
What is the current status of trial NCT05805449?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-02-21. Estimated completion is 2026-03-31.
What conditions does trial NCT05805449 study?
This clinical trial studies the following conditions: Anal Fistula.
What interventions are being tested in trial NCT05805449?
The interventions under investigation include: Surgery (PROCEDURE), Platelet-rich plasma (PRP) (OTHER), Matrix (DEVICE).
Who is sponsoring clinical trial NCT05805449?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RECRUITING · NA
-
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
RECRUITING · Phase 1
-
Myriad™ Augmented Soft Tissue Reconstruction Registry
RECRUITING
-
Evaluating an rhPDGF-BB-enhanced Collagen Plug for Perianal Fistula Healing
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI